Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Congenital Abnormalities
Description
Malformations of organs or body parts during development in utero. MeSH
Hierarchy View
Subtype Terms (20)
Abnormalities, Drug-Induced
4 drugs (3 approved, 1 experimental)
Abnormalities, Radiation-Induced
2 drugs (1 approved, 1 experimental)
Abnormalities, Severe Teratoid
Aicardi Syndrome
5 approved drugs
Cardiovascular Abnormalities
22 drugs (14 approved, 8 experimental)
Chromosome Disorders
3 approved drugs
Congenital Microtia
4 drugs (2 approved, 2 experimental)
Digestive System Abnormalities
Hernias, Diaphragmatic, Congenital
4 drugs (2 approved, 2 experimental)
Musculoskeletal Abnormalities
2 approved drugs
Nervous System Malformations
4 approved drugs
Respiratory System Abnormalities
2 approved drugs
Skin Abnormalities
11 drugs (2 approved, 9 experimental)
Stomatognathic System Abnormalities
Urogenital Abnormalities
3 drugs (2 approved, 1 experimental)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (1)
Phase 1 Indicated Drugs (1)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (24)
Organization Involved with Phase 3 Indications (47)
Organization Involved with Phase 2 Indications (48)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Henan University of Traditional Chinese Medicine
King Edward Medical University
National Institute of Allergy and Infectious Diseases (NIAID)
Organization Involved with Other Experimental Indications (11)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
